Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business
  • interests

Trending on Bing

Biden approval rating
Radio host body found
Graham admonished
Man kills 4, and self
Yellowjackets season 2
Startup valued at $1B
$18 hourly wage
Covid vaccine mandate
FC Barca investigation
Jury for Trump lawsuit
'Vertigo' in the works
14 firms red flagged
Meat behind UTIs?
Limits teens' access
Asylum seekers deal
Dorsey's Block tumbles
Strike ends, no deal
Landing for sick pilot
Ski collision trial
Underwater drone test
TB cases spike in U.S.
Florida sued over ban
Parting ways
Rise in antisemitism
New NCAA assist record
LA Montebello tornado
Hoskins knee tear
TikTok CEO grilled
France visit postponed
700+ migrants rescued
Larson confirms split
US airstrikes in Syria
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
1,130 results
STAT26d
A dozen states sue the FDA in hopes of easing abortion pill restrictions
In the latest flare up over access to the abortion pill, a dozen states filed a lawsuit to force the U.S. Food and Drug Administration to ease restrictions on how mifepristone is prescribed and ...
KRDO28d
FDA moves to ease blood donation restrictions for gay and bisexual men
COLORADO SPRINGS, Colo. (KRDO) -- The U.S. Food and Drug Administration is changing its policy to address future blood shortages and remove the stigma around gay and bisexual men. The change has ...
Fox News13d
FDA issues new mammogram regulations aimed at further breast cancer prevention
Mammogram facilities will need to follow some new rules soon. The U.S. Food and Drug Administration (FDA) on Thursday released updated regulations that require mammogram providers to notify ...
CNBC13d
North Carolina lawmakers intervene to defend abortion pill restrictions in case testing FDA power
Dr. Amy Bryant, a North Carolina physician, sued the state in January to block its restrictions on mifepristone because they go beyond the Food and Drug Administration's regulations. State ...
Health Affairs
13h
DEA Telehealth Proposal Brings Risks, Not Patient Protections
The DEA has proposed changes to telehealth regulations that would require a return to in-person visits for some patients; the open comment period for this proposal ends on March 31.
10d
A perilous prescription: The dangers of unregulated drug ads
During the COVID-19 pandemic, as many stayed home, direct-to-consumer prescription drug advertising—already big business—boomed. Websites, social media, streaming services, and other on-demand ...
This Day3d
COVID-19: Travel Restrictions Ease as US, UK, France Adopt WHO-approved Vaccination
with its attendant public health restrictions. According to reports by Reuters yesterday, the United States had said vaccines that are Food and Drug Administration (FDA)-authorised/approved or ...
2d
Are eased U.S. opioid guidelines too little, too late for chronic pain patients?
Since a 2016 crackdown, millions of Americans in chronic pain have struggled to get opioid prescriptions. With a new rule ...
10d
CDC's new opioid guidelines are too little, too late for chronic pain patients, experts say
In November, the agency eased the guidelines for prescribing opioids for pain, allowing physicians more flexibility.
7don MSN
Chronic pain patients struggle to get opioid prescriptions filled, even as CDC eases guidelines
Millions of people in the US living with chronic pain have struggled to get opioid prescriptions written and filled since ...
1d
Incyte gets FDA approval for new drug to treat rare form of skin cancer
The Food and Drug Administration granted marketing approval Wednesday to Zynyz, a drug developed by Wilmington-based Incyte ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback